<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 22 Apr 2026 14:47:16 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/biogen/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Hope for Alzheimer's Patients: Biogen's Latest Drug Reverses Progression of Disease]]></title><description><![CDATA[A new drug from Biogen called BIIB080 has shown promising early results in reducing levels of tau protein, a toxic protein linked to Alzheimer's disease. A Phase Ib trial found that the drug reduced tau]]></description><link>http://direct.ecency.com/hive-196387/@fragmentarion/hope-for-alzheimers-patients-biogens-latest-drug-reverses-progression-of-disease</link><guid isPermaLink="true">http://direct.ecency.com/hive-196387/@fragmentarion/hope-for-alzheimers-patients-biogens-latest-drug-reverses-progression-of-disease</guid><category><![CDATA[hive-196387]]></category><dc:creator><![CDATA[fragmentarion]]></dc:creator><pubDate>Tue, 04 Apr 2023 07:27:15 GMT</pubDate><enclosure url="https://images.ecency.com/p/7ynYBCHn3PDWE5NzwpSc8a4Zw2uffBBoVYLEFCzpVnKEkER7fLgmD6KA4k7hdt1ceCmw2x3B5XHXqsAqCYiusTiHTuMi3bxpkPr15vtKkrDBHtE7Hb5igbKVhAqiZj1f6aZ3wawbf5pKtZ4z1kVHQrW9DbWV14veQrBxiQ1Sak131GgTneeiV3ttTMbV4N3oqQPvxGX8o3RrcZkimJkQDTEuDMmwHuGMa9m?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Aktienanalyse: Biogen ein Kauf?]]></title><description><![CDATA[Liebe Steemians, liebe Anleger und Börsenfreunde, am letzten Wochenende waren wir bei Freunden im Salzburger Land unterwegs und trafen uns am Abend mit weiteren Bekannten am Wallersee. Es stellte sich]]></description><link>http://direct.ecency.com/deutsch/@mpinvest/aktienanalyse-biogen-ein-kauf</link><guid isPermaLink="true">http://direct.ecency.com/deutsch/@mpinvest/aktienanalyse-biogen-ein-kauf</guid><category><![CDATA[deutsch]]></category><dc:creator><![CDATA[mpinvest]]></dc:creator><pubDate>Wed, 31 Jul 2019 07:50:18 GMT</pubDate><enclosure url="https://images.ecency.com/p/vM1pGHgNcyCXUWJECrZbvn1NMPj1oFGUo3gYfF3NNPRD9aJRPVv32MjNekYppLE7YVpzLFcFf7Tua2Wsmm7rTQQeUn3D8Bv8Juecp2kDoaVvdmR8cozW1RxDu4cx85QJAFyAu8S?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[024 - Does BAN2401 Actually Work? Upcoming Subgroup Analyses]]></title><description><![CDATA[Biogen/Eisai to present updated subgroup analyses on their Phase 2 study looking at their Alzheimer's medicine, BAN2401. This antibody binds to amyloid beta protofibrils, reducing plaques in the brain.]]></description><link>http://direct.ecency.com/biotech/@talkchain/024-does-ban2401-actually-work-upcoming-subgroup-analyses</link><guid isPermaLink="true">http://direct.ecency.com/biotech/@talkchain/024-does-ban2401-actually-work-upcoming-subgroup-analyses</guid><category><![CDATA[biotech]]></category><dc:creator><![CDATA[talkchain]]></dc:creator><pubDate>Sun, 21 Oct 2018 22:07:18 GMT</pubDate><enclosure url="https://images.ecency.com/p/S5Eokt4BcQdk7EHeT1aYjzebg2hC7hkthT45dvFt2Eid4BsZDimSbs2BSx1eNpMKSiSdQcn?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[BIIB - BIOGEN REBOUNDING]]></title><description><![CDATA[Biogen could potentially set up here for a rebound higher from very oversold conditions.]]></description><link>http://direct.ecency.com/biib/@crypt0swede/biib-biogen-rebounding</link><guid isPermaLink="true">http://direct.ecency.com/biib/@crypt0swede/biib-biogen-rebounding</guid><category><![CDATA[biib]]></category><dc:creator><![CDATA[crypt0swede]]></dc:creator><pubDate>Tue, 10 Apr 2018 15:06:42 GMT</pubDate></item><item><title><![CDATA[Global Bleeding Disorders Treatment Market Healthcare Status, Industry Analysis and Forecast 2018]]></title><description><![CDATA[A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Bleeding Disorders Treatment Sales Market Research Report (2018-2025)” which provides an outlook of current]]></description><link>http://direct.ecency.com/healthcare/@johnpark49/global-bleeding-disorders-treatment-market-healthcare-status-industry-analysis-and-forecast-2018</link><guid isPermaLink="true">http://direct.ecency.com/healthcare/@johnpark49/global-bleeding-disorders-treatment-market-healthcare-status-industry-analysis-and-forecast-2018</guid><category><![CDATA[healthcare]]></category><dc:creator><![CDATA[johnpark49]]></dc:creator><pubDate>Thu, 08 Mar 2018 10:04:09 GMT</pubDate></item></channel></rss>